ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 139

Pain and Other Symptoms During The Childhood Of Fibromyalgia Patients

Robert S. Katz1, Alexandra Small2, Ben J. Small3 and Susan Shott4, 1Rush Medical College, Chicago, IL, 2University of Illinois Medical School, Chicago, IL, 3Rush University Medical School, Chicago, IL, 4Rush University Medical Center, Chicago, IL

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: family studies, fibromyalgia and pain

  • Tweet
  • Email
  • Print
Session Information

Title: Fibromyalgia, Soft Tissue Disorders and Pain I

Session Type: Abstract Submissions (ACR)

Background/Purpose: We investigated the severity of pain and other symptoms during childhood, before age 12 and before age 18, that might be related to fibromyalgia (FMS).

Methods: 115 FMS patients and 63 control patients with other rheumatic diseases answered a rheumatology office questionnaire that included questions about symptoms experienced before the ages of 12 and 18. Patients were asked to rate each symptom as 1 = no problem, 2 = seldom, 3 = occasional, 4 = moderate, and 5 = severe problem.  The chi-square test of association and Fisher’s exact test were used to compare percentages, and the Mann-Whitney test was done to compare FMS and control patients with respect to age and symptom severity ratings. A 0.05 significance level was used and all tests were two-sided.

Results: The mean age was 48.1 ±12.3 years for FMS patients and 50.7 ±13.6 for rheumatic disease control patients (p = 0.092). 81.7% of the FMS patients and 61.9% of the control patients were women (p = 0.004). FMS patients had significantly worse severity ratings than did control patients for the following symptoms before age 18 (all with p < 0.001): “growing pains” (FMS 2.1± 1.5 vs. controls 1.4± 0.9), sleep problems (FMS 2.3± 1.4 vs. controls 1.3± 0.9), fatigue (FMS 2.2 ± 1.4 vs. controls 1.4 ±0.9), concentration problems (FMS 2.3 ±1.4 vs. controls 1.5± 0.8), memory problems (FMS 2.2±1.5 vs. controls 1.4 0.8), anxiety (FMS 2.1 ±1.4 vs. controls 1.4± 1.0), headaches (FMS 2.7 ±1.4 vs. controls 1.6 1.0), stomach aches (FMS 2.3 ±1.4 vs. controls 1.3 ±0.8), and depressed mood (FMS 2.1± 1.3 vs. controls 1.3± 0.7).  Similar results were obtained for the same symptoms before age 12 (all with p< 0.022).

Conclusion:  Pain, sleep problems, fatigue, concentration, and memory complaints were reported to be more common before the ages of 18 and before 12 in FMS subjects. Though recall bias could be a limitation of this study, the data suggest that fibromyalgia patients frequently have symptoms in childhood. Other studies have suggested that fibromyalgia may be related to a trait (fibromyalgianess). This study points out that the vulnerability to this illess might be manifested early in life.




Disclosure:

R. S. Katz,
None;

A. Small,
None;

B. J. Small,
None;

S. Shott,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/pain-and-other-symptoms-during-the-childhood-of-fibromyalgia-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology